Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Neoplasia (New York, N.Y.)
|
March 15, 2006
Defining aggressive prostate cancer using a 12-gene model
Tarek A Bismar, Francesca Demichelis, Alberto Riva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
Carey K Anders, David S Hsu, Gloria Broadwater, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2018
Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib
Brian I Rini, Bernard Escudier, Jean-Francois Martini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2017
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop
Kevin S Hughes, Edward P Ambinder, Gregory P Hess, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2011
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology
Phillip G Febbo, Marc Ladanyi, Kenneth D Aldape, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2007
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer
David S Hsu, Bala S Balakumaran, Chaitanya R Acharya, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 29, 2011
NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement
Paul F Engstrom, Mara G Bloom, George Daniel Demetri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)
Andrew B Nixon, Susan Halabi, Yingmiao Liu, et al.
The Journal of Urology
|
November 18, 2011
Utilization trends at a multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center
Suzanne Biehn Stewart, Lionel L Bañez, Cary N Robertson, et al.
European Urology
|
December 4, 2014
A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
Jennifer Cullen, Inger L Rosner, Timothy C Brand, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Neoplasia (New York, N.Y.)
|
March 15, 2006
Defining aggressive prostate cancer using a 12-gene model
Tarek A Bismar, Francesca Demichelis, Alberto Riva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
Carey K Anders, David S Hsu, Gloria Broadwater, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2018
Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib
Brian I Rini, Bernard Escudier, Jean-Francois Martini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2017
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop
Kevin S Hughes, Edward P Ambinder, Gregory P Hess, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2011
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology
Phillip G Febbo, Marc Ladanyi, Kenneth D Aldape, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2007
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer
David S Hsu, Bala S Balakumaran, Chaitanya R Acharya, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 29, 2011
NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement
Paul F Engstrom, Mara G Bloom, George Daniel Demetri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)
Andrew B Nixon, Susan Halabi, Yingmiao Liu, et al.
The Journal of Urology
|
November 18, 2011
Utilization trends at a multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center
Suzanne Biehn Stewart, Lionel L Bañez, Cary N Robertson, et al.
European Urology
|
December 4, 2014
A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
Jennifer Cullen, Inger L Rosner, Timothy C Brand, et al.
Page
of 8